L13b Treatment of Asthma Flashcards

1
Q

Glucocorticoids (GCs)

A

Glucocorticoids (GCs)
•Reduce inflammation and immune responses,
• Used clinically since 1948
• $10,000,000,000./year market size in US (10 billion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glucocorticoids (GCs) Classification

A
Glucocorticoids (GCs) are a class of steroid hormones that bind to the glucocorticoid receptor (GCR). 
The name glucocorticoid (glucose + cortex + steroid) derives from their role in the regulation of the metabolism of glucose, their synthesis in the adrenal cortex, and their steroidal structure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Physiological effects of GCS

A

Regulation of carbohydrate, protein and lipid metabolism
Maintenance of fluid and electrolyte balance Preservation of normal function of the cardiovascular system, the immune system, the kidney, skeletal muscle, the endocrine system and the nervous system
Preservation of organism homeostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Systemic Glucocorticoids (oral)

A
CH2OH= bonding sight
Blue= attached to bonding sight and OH. effects the lipophysity
Cortisone
Prednisone
Dexamethasone
Hydrocortisone (cortisol)
Prednisolone
MEthylprednisolone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inhaled Glucocorticoids

A
Flunisolide
Trimcrinolone Acetonide
Beclomethasone dipropionate
--> No active bonding site.
--> Pro-drug (will become a drug onsite (Inhaled as CH2OCOC2H5 side chain --> separate into CH2OC on site)
--> reduced systematic effects, increases pulmonary retention time
Budesonide
Fluticasone propionate
Mometasone furoate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacokinetics of GC

A

Ideal GCs should have:
Increased lung deposition and pulmonary retention
Increased residence time and high receptor-binding affinity
Rapid clearance, and have an on-site activation of the pro-drug to promote safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cellular and Molecular Effects of GCs

A
GCs suppress (inflammatory cells) circulating eosinophils, basophils, monocytes, mast cells, dendritic cells, and to a smaller degree lymphocytes (particularly T lymphocytes).
Principal effects: (reduced inflammatory responses) inhibit the synthesis, release, and expression of cytokines, inflammatory peptides, chemokines, growth factors, adhesion molecules, and lipid mediators involved in the inflammatory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacodynamics of Glucocorticoids

A

GCs and Glucocorticoids receptor (GCR) binding:

– GC receptors are not transmembrane receptors. Locate in the cell cytoplasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetics of GC diagram

A
  1. GC diffuse through membrane and bind to GC receptor (GR) located in plasma
  2. . Travels through hole reaching the Nucleus
    a) causes Gene activation
    - -> Increased Inflammatory gene transcription
    - -> Increased inflammatory protein (anti-inflammatory mediator release) (GM-CSF, IL-8)
    b) causes Gene Repression
    - -> Decreased Inflammatory gene Transcription (reduces some mediator gene transcription)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GC effect on cells and regulation

A

Reduce inflammatory cell numbers including inhibition of recruitment or migration, activation, survival, and proliferation of cells.
(when combined with B2 agonist) Up-regulation of beta-adrenergic receptors on airway smooth muscle cells (prevent the Polymers of B2 agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GCs in chronic asthma treatment

A

Inhaled GCs treatment can decrease asthma symptoms, number of uses of bronchodilator (decreases chance of tolerance), and frequency of acute asthma symptoms; and can improve lung function and bronchial hyperresponsiveness.
Onset of response: improvement in lung function may be within 1 month (still doesnt immediately stop acute symptoms);
improvement in airway inflammatory markers can be seen as early as 2 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dexamethasone

A

It has no mineralocorticoid effects and has 25 times more potency than hydrocortisone. (oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oral GCs (Prednisone)

A

Prednisone:
– Prednisone is an inactive pro-drug and it is metabolized in liver to form prednisolone (good to take orally in emergency situation)
– The drug has less mineralocorticoid effects, so decreases swelling of ankle, retaining of water and salt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inhaled GCs delivery statistics

A

Inhaled GCs: around 20% of the drug is inhaled to the lung while 80% is deposited in the mouth and swallowed, reaching the systemic circuit and metabolized by liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse effect of GCs

Systemic adverse effects List

A

Osteoporosis with loss of collagens and increased risk of fracture

  • Increase blood pressure
  • Affect central nervous system which decrease depression but become euphoric (happy) -Maybe verbally psychotic
  • Increase risk of cataract
  • Increase chance to have TB (supresses immune responses, increasing chance of having infection)
  • Salt water retention
  • Cushing Syndrome
  • Long term GC use: Increase gluconeogenesis with high glucose level; cause diabetes and protein/muscle breakdown; cause proximal weakness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cushing Syndrome

A

Cushing syndrome:

  • long term use of GCs
  • hypercortisolism promotes distribution of body to trunk, back of neck (buffalo hump) and also face (moon-face), i.e. central obesity with thin arms and legs
17
Q

One common problem of using GCs

A

A lot of patients or parents are allergic to a word “steroid”

  • baby –> hulk
  • steriods are a common structure. GC are different to other steroids (doesnt cause addictive effects)
18
Q

GC’s Local Adverse Effects

A

Hoarseness or dysphonia, cough, and oral candidiasis (thrush) are the most commonly reported problems associated with inhaled GCs, due to immunosuppressant effect and myopathy of the vocal cords.

19
Q

Prevention Local Adverse Effects from GCs

A

Rinse mouth to prevent thrush (can be taken just before brushing your teeth) (when use inhaler)
Spacer: easier administration of drug to the lung and less chance to cause thrush

20
Q

Outgrow of asthma

A

Only 6% of the kids fully “outgrew” their asthma. this means they had no asthma symptoms for atleast one full year
An additional 39% of the kids had improvement in their asthma. These kids only sometimes had asthma symptoms.
Effects of ICS treatment on % of the outgrowing asthma are still not very clear.
Relationship between long-term use of ICS and airway remodelling is not clear

21
Q

Role of CysLTs in Asthma

A
  1. Mucus secretion= LTC4 & LTD4. dose dependant. increase mucus. Submucosal glands and goblet cells.
  2. Ciliary paralysis= CysLTs. Decreased activity of human respiratory cilia.
  3. Macro-molecules= LTD4. Increased blood flow. increased vascular permeability.
  4. Eosinophil Recruitment= LTD4. Increased venopermeability –> extravasation. Increased Edema –> eosinophil infiltration.
  5. Smooth muscle contraction and proliferation = LTC4 and LTD4. Dose dependant - contractile of peripheral and central airways.
  6. Oedema
22
Q

Overall Target of CysLTs in Asthma

A
Target LTC4 or LTD4 (reverse all the effects)
=receptors creating mucus secretion
=dose dependant - increase mucus 
-submucosal glands
-goblet cells
23
Q

Leukotriene-Modifying Drugs for the Treatment of Asthma

A
  1. ZYFLO: 5-Lox Inhibitor

2. SINGULAIR: Leukotrien-receptor antagonist

24
Q

Leukotriene Receptor Antagonists SINGULAIR

A

SINGULAIR
Zafirlucast
Given orally
No studies available for use in critical patients
Use as add-on or alone therapy for mild to moderate asthma
Side effects:
– Headache
– GI disturbance
– Reversible hepatitis and hyperbilirubinemia

25
Q

Leukotriene Receptor Antagonists Prevention and Relaxation

A
  1. Prevent
    – Aspirin induced asthma
    – Exercise induced asthma
    – Decrease both early and late responses to ` allergen
  2. Relax airway in mild asthma
    – Bronchodilator effect = 1/3 of salbutamol
    – Additive bronchodilation effect with B2-agonist
26
Q

Mast cell stabilizer

A

Mast cells have a role in the 1. acute responses (as allergin when directly stimulates muscle cells to release leukotriene, histamine and PGD2)

  1. Laste phase responses still have to go through mast cells (further activate them)
    - if can stabilise mast cells can essentially reverse effect
  2. Cromolyn sodium
  3. Nedocromil sodium
27
Q

Cromolyn Sodium

A

-Non-steroidal (advantage. keeps parents happy)
-Inhibits IgE mediated mediator release from mast
cells (prevents degranulation)
-4-6 week trial therapy may be required (takes alot of time to see if really works)
-Minimal local side effects – cough
-Almost no systemic effects. (stabilizers muscle cells)
-Prevent both early and late asthmatic responses to inhaled allergens.

28
Q

Cromolyn Sodium Effects

A

EFFECTS:
• Prevent both early and late asthmatic responses to inhaled allergens such as pollen
•Reduce airway reactivity resulting from exposure to a range of inhaled irritants such as sulfur dioxide and cold air

29
Q

Other treatments and future directions

A
Immunotherapy  
Anti-IgE therapy  
Magnesium sulfate  
Therapies against TNF-a
Anti–interleukin-5 (IL-5)  
Gene therapy
30
Q

Management of Asthma

A

Lots of different drugs available
Done on the basis of patients:
1. condition
2. different stage

31
Q

Asthma Prevention

A

Remarkable progress in pharmacotherapy (alot of drugs availble to treat), education and environmental measures in treating asthma
However, no single action has been demonstrated to decrease the risk of developing asthma (real cause of asthma still isnt clear)
–> therefore need more research to improve
Prevention will depend on factors influencing the development and progression of asthma